NTHI insider buys 1,100 shares at $6.69, now holds 134,260

Neonc Technologies Holdings, Inc. (NTHI) disclosed an insider stock purchase by its Chief Clinical Officer on a Form 4.

Rhea-AI Filing Summary

Neonc Technologies Holdings, Inc. (NTHI) disclosed an insider stock purchase by its Chief Clinical Officer on a Form 4. On 11/20/2025, the officer bought 1,100 shares of common stock at a price of $6.69 per share in an open-market transaction coded as a purchase ("P"). After this transaction, the officer beneficially owned 134,260 shares of Neonc Technologies common stock, held directly.

Insider Trade Summary

Net Buyer: 1,100 shares

Net Buy 1 txn

Insider Neman-Ebrahim Yousha

Role Chief Clinical Officer

Bought 1,100 shs ($7K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,100	$6.69	$7K

Holdings After Transaction: Common Stock — 134,260 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NTHI report in this Form 4?

Neonc Technologies Holdings, Inc. reported that its Chief Clinical Officer purchased 1,100 shares of common stock in an open-market transaction.

At what price were the NTHI shares purchased in the reported transaction?

The reported purchase price was $6.69 per share of Neonc Technologies common stock.

How many NTHI shares does the insider own after this transaction?

Following the reported transaction, the officer beneficially owned 134,260 shares of Neonc Technologies common stock, held directly.

What is the role of the reporting person at Neonc Technologies (NTHI)?

The reporting person is an officer of Neonc Technologies Holdings, Inc., serving as the Chief Clinical Officer.

When did the NTHI insider stock purchase take place?

The transaction date for the insider purchase was 11/20/2025, as disclosed in the Form 4.

Was this NTHI Form 4 filed for one or multiple reporting persons?

The Form 4 was indicated as filed by one reporting person, not a group filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/24/2025 - 05:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Neman-Ebrahim Yousha

(Last) (First) (Middle)

23975 PARK SORRENTO

SUITE 205

(Street)

CALABASAS CA 91302

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NEONC TECHNOLOGIES HOLDINGS, INC. [ NTHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Clinical Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/20/2025		P		1,100	A	$6.69	134,260	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Yousha Neman-Ebrahim	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.